Company Analysis

DataMeds AI, Inc. (MEDS)

Nasdaq: MEDS · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Tampa, FL · filing with the SEC since 2024
Grade3.1
◀ Past 2.7● Present 2.7▶ Future 4.1
4 est.

Who runs DataMeds AI, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Patel Prashant
Chief Executive Officer. First filing Mar 2025, latest Jun 25, 2026, 0 filings in all.
Officers reporting now
1
of 9 people with a filing in the last fifteen months
Directors reporting now
8
17 people on the record since 2025
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Patel PrashantChief Executive OfficerMar 2025Jun 25, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Ajjarapu Surendra KdirectorFeb 2025Jun 25, 2026none
Herman Gary LdirectorApr 2026Apr 10, 2026none
Sherb Eric MichaeldirectorApr 2026Apr 9, 2026none
Velez MarlenedirectorApr 2026Apr 2, 2026none
Doss Howard A.directorOct 2025Oct 24, 2025none
Fell Donald G.directorOct 2025Oct 21, 2025none
Lee Steven DaledirectorOct 2025Oct 14, 2025none
Peterson Michael LdirectorJul 2025Jul 8, 2025none
Earlier names on the record8, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton MEDS · research, not advice